Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$32.4 - $68.18 $66.1 Million - $139 Million
-2,038,867 Reduced 46.09%
2,384,677 $162 Million
Q2 2022

Aug 15, 2022

BUY
$22.3 - $37.39 $21.6 Million - $36.2 Million
967,532 Added 28.0%
4,423,544 $141 Million
Q1 2022

May 16, 2022

BUY
$25.68 - $35.59 $7.32 Million - $10.1 Million
284,877 Added 8.98%
3,456,012 $120 Million
Q4 2021

Feb 14, 2022

BUY
$24.9 - $40.26 $1.58 Million - $2.55 Million
63,408 Added 2.04%
3,171,135 $92.8 Million
Q3 2021

Nov 15, 2021

BUY
$25.48 - $37.34 $20.6 Million - $30.1 Million
806,900 Added 35.07%
3,107,727 $79.2 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $14.6 Million - $19.5 Million
449,419 Added 24.27%
2,300,827 $80.6 Million
Q1 2021

May 17, 2021

SELL
$38.94 - $50.85 $16.5 Million - $21.6 Million
-424,301 Reduced 18.64%
1,851,408 $75.4 Million
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $23.9 Million - $40.5 Million
635,550 Added 38.75%
2,275,709 $98.6 Million
Q3 2020

Nov 10, 2020

BUY
$52.76 - $74.49 $3.74 Million - $5.29 Million
70,954 Added 4.52%
1,640,159 $90.4 Million
Q2 2020

Aug 14, 2020

SELL
$48.73 - $81.82 $30.1 Million - $50.6 Million
-618,178 Reduced 28.26%
1,569,205 $99.1 Million
Q1 2020

May 11, 2020

BUY
$41.72 - $87.2 $91.3 Million - $191 Million
2,187,383 New
2,187,383 $112 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.